P.O.Box 2345 Beijing 100023, China Fax: +86-10-85381893 Email: wcjd@wjgnet.com www.wjgnet.com World Chin J Digestol 2004 January;12(1):172-176 ISSN 1009-3079 CN 14-1260/R REVIEW http://www.wjgnet.com/1009-3079/12/172.asp
173
174 ISSN 1009-3079 CN 14-1260/R β
175 syndrome. Am J Gastroenterol 2003;98:750-758 survey of patients. BMJ 1997;314:779-782 1999;318:565-566 syndrome. Am J Gastroenterol 2000;95:3503-3506 Options Gastroenterol 2001;4:287-291 6:283-288 Scand J Gastroenterol Suppl 2003;237:1-8 Immunol 2002;22:255-273 Lancet 2003;361:512-519 Br J Nutr 2002;88(Suppl 1):s67-s72 Nurs 2003;24:192-193 and gut disorder. Inflamm Bowel Dis 2001;7:136-145 perspective. Int J Food Microbiol 2002;78:99-117 acid production. Proc Nutr Soc 2003;62:67-72 responses. Int J Med Microbiol 2003;293:77-86 flora. Br J Nutr 2002;88(Suppl 1):s39-s49 Escherichia coli (EIEC). Gut 2003;52:988-997 healthy volunteers. J Dairy Res 2003;70:165-173 1 Thompson WG, Longstreth GF, Drossman DA, Heaton KW, Irvine EJ, Muller-Lissner SA. Functional bowel disorders and functional abdominal pain. Gut 1999;45(Suppl 2):II43-II47 2 Hasler WL. The irritable bowel syndrome. Med Clin North Am 2002;86:1525-1551 3 Somers SC, Lembo A. Irritable bowel syndrome: evaluation and treatment. Gastroenterol Clin North Am 2003;32:507-529 4 Berrada D, Canenguez K, Lembo T. New approaches to the medical treatment of irritable bowel syndrome. Curr Gastroenterol Rep 2003;5:337-342 5 Talley NJ. Pharmacologic therapy for the irritable bowel 6 Neal KR, Hebden J, Spiller R. Prevalence of gastrointestinal symptoms six months after bacterial gastroenteritis and risk factors for development of the irritable bowel syndrome: postal 7 Rodriguez LA, Ruigomez A. Increased risk of irritable bowel syndrome after bacterial gastroenteritis: cohort study.bmj 8 Pimentel M, Chow EJ, Lin HC. Eradication of small intestinal bacterial overgrowth reduces symptoms of irritable bowel 9 Gwee KA. Postinfectious irritable bowel syndrome. Curr Treat 10 Floch MH. Probiotics, Irritable bowel syndrome, and inflammatory bowel disease. Curr Treat Options Gastroenterol 2003; 11 Quigley EM. Current concepts of the irritable bowel syndrome. 12 Marteau PR. Probiotics in clinical conditions. Clin Rev Allergy 13 Guarner F, Malagelada JR. Gut flora in health and disease. 14 Madden JA, Hunter JO. A review of the role of the gut microflora in irritable bowel syndrome and the effects of probiotics. 15 Yen PK. Probiotics and prebiotics for bowel health. Geriatr 16 Dunne C. Adaptation of bacteria to the intestinal niche: probiotics 17 Saarela M, Lahteenmaki L, Crittenden R, Salminen S, Mattila- Sandholm T. Gut bacteria and health foods-the European 18 Macfarlane S, Macfarlane GT. Regulation of short-chain fatty 19 Rolfe RD. The role of probiotic cultures in the control of gastrointestinal health. J Nutr 2000;130(Suppl 2):s396-s402 20 Gardiner GE, Ross RP, Wallace JM, Scanlan FP, Jagers PP, Fitzgerald GF, Collins JK, Stanton C. Influence of a probiotic adjunct culture of Enterococcus faecium on the quality of cheddar cheese. J Agric Food Chem 1999;47:4907-4916 21 Heller F, Duchmann R. Intestinal flora and mucosal immune 22 Fooks LJ, Gibson GR. Probiotics as modulators of the gut 23 Sullivan A, Barkholt L, Nord CE. Lactobacillus acidophilus, Bifidobacterium lactis and Lactobacillus F19 prevent antibiotic-associated ecological disturbances of Bacteroides fragilis in the intestine. J Antimicrob Chemother 2003;52:308-311 24 Resta-Lenert S, Barrett KE. Live probiotics protect intestinal epithelial cells from the effects of infection with enteroinvasive 25 Schultz M, Linde HJ, Lehn N, Zimmermann K, Grossmann J, Falk W, Scholmerich J. Immunomodulatory consequences of oral administration of Lactobacillus rhamnosus strain GG in 26 Liu Q, Nobaek S, Adawi D, Mao Y, Wang M, Molin G, Ekelund M, Jeppsson B. Administration of Lactobacillus plantarum 299v reduces side-effects of external radiation on colon anastomotic healing in an experimental model. Colorectal Dis 2001; 3:245-252 27 McCarthy J, O Mahony L, O Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, Fitzgibbon J, O Sullivan GC, Kiely B, Collins JK, Shanahan F. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 2003;52:975-980 28 Perdigon G, Locascio M, Medici M, Pesce de Ruiz Holgado A, Oliver G. Interaction of bifidobacteria with the gut and their influence in the immune function. Biocell 2003;27:1-9 29 Annuk H, Shchepetova J, Kullisaar T, Songisepp E, Zilmer M, Mikelsaar M. Characterization of intestinal lactobacilli as putative probiotic candidates. J Appl Microbiol 2003;94:403-412 30 Montalto M, Arancio F, Izzi D, Cuoco L, Curigliano V, Manna
176 ISSN 1009-3079 CN 14-1260/R R, Gasbarrini G. Probiotics: history, definition, requirements and possible therapeutic applications. Ann Ital Med Int 2002; 17:157-165 31 Marteau P, Seksik P, Jian R. Probiotics and intestinal health effects: a clinical perspective. Br J Nutr 2002;88(Suppl 1):s51-s57 32 Fric P. Probiotics in gastroenterology. Gastroenterology 2002; 40:197-201 33 Reid G, Sanders ME, Gaskins HR, Gibson GR, Mercenier A, Rastall R, Roberfroid M, Rowland I, Cherbut C, Klaenhammer TR. New scientific paradigms for probiotics and prebiotics. J Clin Gastroenterol 2003;37:105-118 34 Drisko JA, Giles CK, Bischoff BJ. Probiotics in health maintenance and disease prevention. Altern Med Rev 2003;8:143-155 35 Kennedy RJ, Kirk SJ, Gardiner KR. Probiotics. Br J Surg 2001; 88:1018-1019 36 Ouwehand A, Vesterlund S. Health aspects of probiotics. IDrugs 2003;6:573-580 37 Kalliomaki M, Isolauri E. Role of intestinal flora in the development of allergy. Curr Opin Allergy Clin Immunol 2003;3:15-20 38 Shanahan F. Probiotics in inflamatory bowel disease. Gut 2001; 48:609 39 Kwon J, Farrell R. Probiotics and inflammatory bowel disease. Bio Drugs 2003;17:179-186 40 Guslandi M, Giollo P, Testoni PA. A pilot trial of Saccharomyces boulardii in ulcerative colitis. Eur J Gastroenterol Hepatol 2003;15:697-698 41 Ishikawa H, Akedo I, Umesaki Y, Tanaka R, Imaoka A, Otani T. Randomized controlled trial of the effect of bifidobacteriafermented milk on ulcerative colitis. J Am Coll Nutr 2003;22: 56-63 42 Karthik SV. Probiotics in inflammatory bowel disease. J R Soc Med 2003;96:370 43 Famularo G, Mosca L, Minisola G, Trinchieri V, De Simone C. Probiotic lactobacilli: a new perspective for the treatment of inflammatory bowel disease. Curr Pharm Des 2003;9:1973-1980 44 Charlesworth EN. Probiotics in primary prevention of atopic disease. Curr Allergy Asthma Rep 2003;3:281 45 Vanderhoof JA, Young RJ. Role of probiotics in the management of patients with food allergy. Ann Allergy Asthma Immunol 2003;90(6 Suppl 3):s99-s103 46 Takayama F, Taki K, Niwa T. Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. Am J Kidney Dis 2003;41(3 Suppl 1):s142-s145 47 Solga SF. Probiotics can treat hepatic encephalopathy. Med Hypotheses 2003;61:307-313 48 Van den Driessche M, Veereman-Wauters G. Functional foods in pediatrics. Acta Gastroenterol Belg 2002;65:45-51 49 Vanderhoof JA, Young RJ. Use of probiotics in childhood gastrointestinal disorders. J Pediatr Gastroenterol Nutr 1998;27: 323-332 50 Smejkal C, Kolida S, Bingham M, Gibson G, McCartney A. Probiotics and prebiotics in female health. J Br Menopause Soc 2003;9:69-74 51 Mendall MA, Kumar D. Antibiotic use, childhood affluence and irritable bowel syndrome (IBS). Eur J Gastroenterol Hepatol 1998;10:59-62 52 Balsari A, Ceccarelli A, Dubini F, Fesce E, Poli G. The fecal microbial population in the irritable bowel syndrome. Microbiologica 1982;5:185-194 53 Bradley HK, Wyatt GM, Bayliss CE, Hunter JO. Instability in the faecal flora of a patient suffering from food-related irritable bowel syndrome. J Med Microbiol 1987;23:29-32 54 Wyatt GM, Bayliss CE, Lakey AF, Bradley HK, Hunter JO, Jones VA. The faecal flora of two patients with food-related irritable bowel syndrome during challenge with symptomprovoking foods. J Med Microbiol 1988;26:295-299 55 Floch MH, Narayan R. Diet in the irritable bowel syndrome. J Clin Gastroenterol 2002;35(1 Suppl)s45-s52 56 Nanda R, James R, Smith H, Dudley CR, Jewell DP. Food intolerance and the irritable bowel syndrome. Gut 1989;30: 1099-1104 57 Zar S, Kumar D, Benson MJ. Food hypersensitivity and irritable bowel syndrome. Aliment Pharmacol Ther 2001;15:439-449 58 King TS, Elia M, Hunter JO. Abnormal colonic fermentation in irritable bowel syndrome. Lancet 1998;352:1187-1189 59 Rath HC. The role of endogenous bacterial flora: bystander or the necessary prerequisite? Eur J Gastroenterol Hepatol 2003; 15:615-620 60 Halpern GM, Prindiville T, Blankenburg M, Hsia T, Gershwin ME.Treatment of irritable bowel syndrome with Lacteol Fort: a randomized, double-blind, cross-over trial. Am J Gastroenterol 1996;91:1579-1585 61 Niedzielin K, Kordecki H, Birkenfeld B.A controlled, doubleblind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol 2001;13:1143-1147 62 Nobaek S, Johansson ML, Molin G, Ahrne S, Jeppsson B.Alteration of intestinal microflora is associated with reduction in a bdominal bloating and pain in patients with irritable bowel syndrome. Am J Gastroenterol 2000;95:1231-1238 63 Sen S, Mullan MM, Parker TJ, Woolner JT, Tarry SA, Hunter JO. Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome. Dig Dis Sci 2002;47:2615-2620 64 O Sullivan MA, O Morain CA. Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study. Dig Liver Dis 2000;32:294-301 65 1999;11:164-166 66 Brigidi P, Vitali B, Swennen E, Bazzocchi G, Matteuzzi D. Effects of probiotic administration upon the composition and enzymatic activity of human fecal microbiota in patients with irritable bowel syndrome or functional diarrhea. Res Microbiol 2001;152:735-741 67 2003;8( ):A11-23 68 Kim HJ, Camilleri M, McKinzie S, Lempke MB, Burton DD, Thomforde GM, Zinsmeister AR. A randomized controlled trial of a probiotic, VSL#3, on gut transit and symptoms in diarrhoea-predominant irritable bowel syndrome. Aliment Pharmacol Ther 2003;17:895-904 69 Bazzocchi G, Gionchetti P, Almerigi PF, Amadini C, Campieri M. Intestinal microflora and oral bacteriotherapy in irritable bowel syndrome. Dig Liver Dis 2002;34(Suppl 1):s48-s53 70 Holmes S. Are probiotics and other functional foods the medicines of the future? Prof Nurse 2003;18:627-630 71 1999;26:93-96 72 Dunlop SP, Jenkins D, Spiller RC. Distinctive clinical, psychological, and histological features of postinfective irritable bowel syndrome. Am J Gastroenterol 2003;98:1578-1583 73 Barbara G, Corinaldesi R. Probiotics: could they turn out to be ineffective in irritable bowel syndrome? Dig Liver Dis 2000; 32:302-304 74 Faber SM. Are probiotics useful in irritable bowel syndrome? J Clin Gastroenterol 2003;37:93-94 75 Thompson WG. Probiotics for irritable bowel syndrome: a light in the darkness? Eur J Gastroenterol Hepatol 2001;13: 1135-1136 76 Gorbach SL. Probiotics in the third millennium. Dig Liver Dis 2002;34(Suppl 2):s2-s7